Prime Minister Mostafa Madbouly reaffirmed the State’s commitment to ensuring the sustainable and efficient supply of medical necessities for all citizens.
He stressed that the government is placing the settlement of arrears owed to the Management of Medical Technology (UPA) suppliers at the forefront of its agenda to safeguard corporate financial stability and ensure the continuity of medical supply chains.
The prime minister’s remarks came during a meeting held today, April 7, 2026, to review the UPA’s financial standing and the latest developments regarding payments to suppliers.
The session was attended by Minister of Planning and Economic Development Ahmed Rostom, Presidential Advisor for Financial Affairs Ahmed al-Shazly, UPA Chairman Hisham Stait, and several senior officials from the Ministries of Finance and Health.
Madbouly stated that resolving the financial challenges facing the UPA is a top priority to guarantee the uninterrupted delivery of services across state-affiliated hospitals.
He added that fulfilling contractual obligations is essential to fostering an attractive investment climate for both international and local pharmaceutical and medical equipment manufacturers.
Cabinet Spokesperson Mohamed al-Homsani stated that the meeting included a comprehensive review of the UPA’s debt profile and financial allocations.
Discussions focused on mechanisms to secure the necessary cash flows to meet supplier payments according to agreed-upon timelines. He noted that coordination is ongoing between the UPA and the ministries of finance and planning to expedite the collection of debts owed to the Authority by various state entities.
The spokesperson added that the meeting also reviewed the latest updates on the upgraded “MedIQ” digital system.
The new portal represents a qualitative leap in procurement governance through integrated financial linking, allowing for precise tracking and real-time auditing of supplier entitlements.
Concluding the meeting, Madbouly directed officials to intensify efforts to implement a comprehensive settlement plan.
He added that these measures serve as a clear message of reassurance to global and local investors, reflecting the state’s dedication to a stable business environment that supports the growth of the pharmaceutical industry and the localization of modern medical technology in Egypt.
